Mutated Circulating Tumor DNA as a Liquid Biopsy in Lung Cancer Detection and Treatment

0
8
The authors discuss future perspectives of early-cancer detection and clonal hematopoiesis filtering strategies, with possible inclusion of microbiome-driven liquid biopsy.
[Molecular Oncology]
Filipska, M., & Rosell, R. (2021). Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment. Molecular Oncology, 15(6), 1667–1682. https://doi.org/https://doi.org/10.1002/1878-0261.12983 Cite
Abstract